OSE Immunotherapeutics SA (EPA:OSE)
5.71
+0.38 (7.13%)
Nov 10, 2025, 5:35 PM CET
OSE Immunotherapeutics Employees
OSE Immunotherapeutics had 64 employees as of December 31, 2024. The number of employees increased by 9 or 16.36% compared to the previous year.
Employees
64
Change (1Y)
9
Growth (1Y)
16.36%
Revenue / Employee
€1,303,672
Profits / Employee
€585,078
Market Cap
119.50M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 64 | 9 | 16.36% |
| Dec 31, 2023 | 55 | -12 | -17.91% |
| Dec 31, 2022 | 67 | 6 | 9.84% |
| Dec 31, 2021 | 61 | 10 | 19.61% |
| Dec 31, 2020 | 51 | 9 | 21.43% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| emeis Société anonyme | 83,494 |
| Sanofi | 82,878 |
| Eurofins Scientific SE | 62,696 |
| Clariane SE | 61,798 |
| bioMérieux | 14,754 |
| Sartorius Stedim Biotech | 9,901 |
| Virbac | 6,365 |
OSE Immunotherapeutics News
- 5 weeks ago - OSE Immunotherapeutics (ORPOF) Appoints Interim CEO Marc Le Bozec - GuruFocus
- 5 weeks ago - OSE Immunotherapeutics replaces CEO Nicolas Poirier, appoints Marc Le Bozec as interim CEO - Seeking Alpha
- 7 weeks ago - OSE Immunotherapeutics SA (ORPOF) Shareholder/Analyst Call Transcript - Seeking Alpha